Related references
Note: Only part of the references are listed.Thrombospondin-4 in tissue remodeling
Olga Stenina-Adognravi et al.
MATRIX BIOLOGY (2019)
Non-Smad Signaling Pathways of the TGF-β Family
Ying E. Zhang
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2017)
Thrombospondin-4 mediates TGF-β-induced angiogenesis
S. Muppala et al.
ONCOGENE (2017)
TGF-β1 promotes scar fibroblasts proliferation and transdifferentiation via up-regulating MicroRNA-21
Ying Liu et al.
SCIENTIFIC REPORTS (2016)
Extracellular Matrix and Dermal Fibroblast Function in the Healing Wound
Lauren E. Tracy et al.
ADVANCES IN WOUND CARE (2016)
Characterization of the MMP/TIMP Imbalance and Collagen Production Induced by IL-1β or TNF-α Release from Human Hepatic Stellate Cells
Sacha Robert et al.
PLOS ONE (2016)
The molecular basis of hypertrophic scars
Zhensen Zhu et al.
BURNS & TRAUMA (2016)
Proangiogenic Properties of Thrombospondin-4
Santoshi Muppala et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2015)
Invoking the power of thrombospondins: Regulation of thrombospondins expression
Olga Stenina-Adognravi
MATRIX BIOLOGY (2014)
Control of organization and function of muscle and tendon by thrombospondin-4
Ella G. Frolova et al.
MATRIX BIOLOGY (2014)
The Anti-Scar Effects of Basic Fibroblast Growth Factor on the Wound Repair In Vitro and In Vivo
Hong-Xue Shi et al.
PLOS ONE (2013)
Critical Role of Transforming Growth Factor Beta in Different Phases of Wound Healing
Mohammadreza Pakyari et al.
ADVANCES IN WOUND CARE (2013)
Enhanced isolation of fibroblasts from human skin explants
Lily I. Huschtscha et al.
BIOTECHNIQUES (2012)
Thrombospondin-4 regulates fibrosis and remodeling of the myocardium in response to pressure overload
Ella G. Frolova et al.
FASEB JOURNAL (2012)
The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups
Christina Curtis et al.
NATURE (2012)
Gene Expression Signature-Based Prognostic Risk Score in Gastric Cancer
Jae Yong Cho et al.
CLINICAL CANCER RESEARCH (2011)
Fibroblasts and myofibroblasts in wound healing: Force generation and measurement
Bin Li et al.
JOURNAL OF TISSUE VIABILITY (2011)
Thrombospondin-4 Regulates Vascular Inflammation and Atherogenesis
Ella G. Frolova et al.
CIRCULATION RESEARCH (2010)
Burn Therapists' Opinion on the Application and Essential Characteristics of a Burn Scar Outcome Measure
Lisa Forbes-Duchart et al.
JOURNAL OF BURN CARE & RESEARCH (2009)
Analyzing real-time PCR data by the comparative C-T method
Thomas D. Schmittgen et al.
NATURE PROTOCOLS (2008)
Antisense inhibition of connective tissue growth factor (CTGF/CCN2) mRNA limits hypertrophic scarring without affecting wound healing in vivo
Mark Sisco et al.
WOUND REPAIR AND REGENERATION (2008)
Decorin-transforming growth factor-β interaction regulates matrix organization and mechanical characteristics of three-dimensional collagen matrices
Zannatul Ferdous et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Recombinant human decorin inhibits cell proliferation and downregulates TGF-β1 production in hypertrophic scar fibroblasts
Zhi Zhang et al.
BURNS (2007)
Characterization of SIS3, a novel specific inhibitor of Smad3, and its effect on transforming growth factor-β1-induced extracellular matrix expression
M Jinnin et al.
MOLECULAR PHARMACOLOGY (2006)
Hypertrophic scar fibroblasts have increased connective tissue growth factor expression after transforming growth factor-β stimulation
AS Colwell et al.
PLASTIC AND RECONSTRUCTIVE SURGERY (2005)
Crosstalk mechanisms between the mitogen-activated protein kinase pathways and Smad signaling downstream of TGF-β:: implications for carcinogenesis
D Javelaud et al.
ONCOGENE (2005)
Modulation of the TGFβ/Smad signaling pathway in mesangial cells by CTGF/CCN2
NA Wahab et al.
EXPERIMENTAL CELL RESEARCH (2005)
Smad-dependent and Smad-independent pathways in TGF-β family signalling
R Derynck et al.
NATURE (2003)
SB-431542 is a potent and specific inhibitor of transforming growth factor-β superfamily type I activin receptor-like kinase (ALK) receptors ALK4, ALK5, and ALK7
GJ Inman et al.
MOLECULAR PHARMACOLOGY (2002)
Gene expression correlates of clinical prostate cancer behavior
D Singh et al.
CANCER CELL (2002)
SB203580, a specific inhibitor of p38-MAPK pathway, is a new reversal agent of P-glycoprotein-mediated multidrug resistance
M Barancík et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2001)
Thrombospondin-4 binds specifically to both collagenous and non-collagenous extracellular matrix proteins via its C-terminal domains
L Narouz-Ott et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Share Paper
